Market Overview:
The global biosurgery market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the biosurgery market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in the field of biosurgery. Based on type, the global biosurgery market is segmented into surgical sealants, hemostatic agents, adhesion barriers, bone graft substitutes, staple line reinforcement agents and others. Surgical sealants are further sub-segmented into fibrin sealants and adhesive sealants. Hemostatic agents are further sub-segmented into thrombin inhibitors/clotting factors and platelet inhibitors/activators. Adhesion barriers are further sub-segmented into bioadhesives and surface coatings/barriers.
Product Definition:
Biosurgery is the surgical intervention on biological tissue, e.g., removal of a tumor, with an instrument or device.
Surgical Sealants:
Surgical sealants are synthetic or natural materials that are used to close wounds during surgeries. The most common types of sealants include collagen, surgical cotton, and hydrogels. They can be used in various applications including orthopedic, cardiovascular & neurosurgery and general surgery.
Hemostatic Agents:
Hemostatic agents are substances that act as a substitute for blood and help maintain the integrity of tissues. It is majorly used in wound healing process. Some of the common hemostatic agents include Celox, Tissue Plasminogen Activator (tPA), and urokinase.
Application Insights:
The general surgeries segment dominated the global market in 2017 owing to increasing number of general surgery procedures. General surgeries include all types of surgical procedures that are not specifically related to the abdominal cavity, thoracic cavity, or pelvic region. According to a study published by NCBI in 2018, around 54% of total surgeries were performed on patients aged 65 years and above which is expected to boost overall market growth during forecast period.
The orthopedic surgeries segment is also expected witness significant growth over the forecast period due largely to increase in sports-related injuries and prevalence of bone diseases across various regions globally. For instance, as per WHO estimates around 1 billion people suffer from some form of arthritis while another 1/3rd suffers from some form of musculoskeletal pain every year globally which is expected drive demand for biosurgery during the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing prevalence of orthopedic, cardiovascular, neurological and other chronic diseases. In addition, an increase in surgical procedures due to accidents/injuries as well as rising awareness about minimally invasive surgeries is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to a large population base with high unmet medical needs coupled with rapidly improving healthcare infrastructure and growing patient awareness levels regarding advanced treatment options for various disorders. Moreover, economic development coupled with government initiatives aimed at reducing healthcare expenditure will boost demand for biosurgery products over the coming years.
Growth Factors:
- Increasing incidence of chronic diseases: The global biosurgery market is expected to grow at a CAGR of over 7% during the forecast period owing to the increasing incidence of chronic diseases such as cancer, diabetes, and arthritis.
- Rising demand for minimally invasive surgeries: The growth of the biosurgery market is also attributed to the rising demand for minimally invasive surgeries which are less traumatic and offer shorter recovery times as compared to traditional surgery procedures.
- Technological advancements in biosurgery products: The advent of novel technologies in biosurgery products such as tissue engineering and regenerative medicine is propelling the growth of this market. These technologies are helping surgeons achieve better outcomes with fewer complications post-surgery.
- Growing geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive the demand for advanced surgical procedures such as biosurgeries over the next few years. Elderly patients are more susceptible to chronic diseases which can be treated through surgical interventions such as biosurgeries.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biosurgery Market Research Report
By Type
Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Bone Graft Substitutes, Staple Line Reinforcement Agents
By Application
Neurological Surgeries, Cardiovascular Surgeries, General Surgeries, Orthopedic Surgeries, Thoracic Surgeries, Gynecology Surgeries, Urology Surgeries, Reconstructive Surgeries
By Companies
Baxter International, C.R. Bard, Johnson & Johnson, Medtronic, Getinge Group, B. Braun Melsungen AG, Cryolife, Stryker Corporation, Hemostasis, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Biosurgery Market Report Segments:
The global Biosurgery market is segmented on the basis of:
Types
Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Bone Graft Substitutes, Staple Line Reinforcement Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neurological Surgeries, Cardiovascular Surgeries, General Surgeries, Orthopedic Surgeries, Thoracic Surgeries, Gynecology Surgeries, Urology Surgeries, Reconstructive Surgeries
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International
- C.R. Bard
- Johnson & Johnson
- Medtronic
- Getinge Group
- B. Braun Melsungen AG
- Cryolife
- Stryker Corporation
- Hemostasis
- Sanofi
Highlights of The Biosurgery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical Sealants
- Hemostatic Agents
- Adhesion Barriers
- Bone Graft Substitutes
- Staple Line Reinforcement Agents
- By Application:
- Neurological Surgeries
- Cardiovascular Surgeries
- General Surgeries
- Orthopedic Surgeries
- Thoracic Surgeries
- Gynecology Surgeries
- Urology Surgeries
- Reconstructive Surgeries
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biosurgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biosurgery is a medical treatment that uses biologic agents to treat disease. These agents can be used to destroy cancer cells, remove plaque from the arteries, or reduce inflammation.
Some of the major players in the biosurgery market are Baxter International, C.R. Bard, Johnson & Johnson, Medtronic, Getinge Group, B. Braun Melsungen AG, Cryolife, Stryker Corporation, Hemostasis, Sanofi.
The biosurgery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biosurgery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biosurgery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biosurgery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biosurgery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biosurgery Market Size & Forecast, 2020-2028
4.5.1 Biosurgery Market Size and Y-o-Y Growth
4.5.2 Biosurgery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Surgical Sealants
5.2.2 Hemostatic Agents
5.2.3 Adhesion Barriers
5.2.4 Bone Graft Substitutes
5.2.5 Staple Line Reinforcement Agents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Neurological Surgeries
6.2.2 Cardiovascular Surgeries
6.2.3 General Surgeries
6.2.4 Orthopedic Surgeries
6.2.5 Thoracic Surgeries
6.2.6 Gynecology Surgeries
6.2.7 Urology Surgeries
6.2.8 Reconstructive Surgeries
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biosurgery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biosurgery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Surgical Sealants
9.6.2 Hemostatic Agents
9.6.3 Adhesion Barriers
9.6.4 Bone Graft Substitutes
9.6.5 Staple Line Reinforcement Agents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Neurological Surgeries
9.10.2 Cardiovascular Surgeries
9.10.3 General Surgeries
9.10.4 Orthopedic Surgeries
9.10.5 Thoracic Surgeries
9.10.6 Gynecology Surgeries
9.10.7 Urology Surgeries
9.10.8 Reconstructive Surgeries
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Surgical Sealants
10.6.2 Hemostatic Agents
10.6.3 Adhesion Barriers
10.6.4 Bone Graft Substitutes
10.6.5 Staple Line Reinforcement Agents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Neurological Surgeries
10.10.2 Cardiovascular Surgeries
10.10.3 General Surgeries
10.10.4 Orthopedic Surgeries
10.10.5 Thoracic Surgeries
10.10.6 Gynecology Surgeries
10.10.7 Urology Surgeries
10.10.8 Reconstructive Surgeries
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Surgical Sealants
11.6.2 Hemostatic Agents
11.6.3 Adhesion Barriers
11.6.4 Bone Graft Substitutes
11.6.5 Staple Line Reinforcement Agents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Neurological Surgeries
11.10.2 Cardiovascular Surgeries
11.10.3 General Surgeries
11.10.4 Orthopedic Surgeries
11.10.5 Thoracic Surgeries
11.10.6 Gynecology Surgeries
11.10.7 Urology Surgeries
11.10.8 Reconstructive Surgeries
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Surgical Sealants
12.6.2 Hemostatic Agents
12.6.3 Adhesion Barriers
12.6.4 Bone Graft Substitutes
12.6.5 Staple Line Reinforcement Agents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Neurological Surgeries
12.10.2 Cardiovascular Surgeries
12.10.3 General Surgeries
12.10.4 Orthopedic Surgeries
12.10.5 Thoracic Surgeries
12.10.6 Gynecology Surgeries
12.10.7 Urology Surgeries
12.10.8 Reconstructive Surgeries
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Surgical Sealants
13.6.2 Hemostatic Agents
13.6.3 Adhesion Barriers
13.6.4 Bone Graft Substitutes
13.6.5 Staple Line Reinforcement Agents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Neurological Surgeries
13.10.2 Cardiovascular Surgeries
13.10.3 General Surgeries
13.10.4 Orthopedic Surgeries
13.10.5 Thoracic Surgeries
13.10.6 Gynecology Surgeries
13.10.7 Urology Surgeries
13.10.8 Reconstructive Surgeries
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biosurgery Market: Competitive Dashboard
14.2 Global Biosurgery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter International
14.3.2 C.R. Bard
14.3.3 Johnson & Johnson
14.3.4 Medtronic
14.3.5 Getinge Group
14.3.6 B. Braun Melsungen AG
14.3.7 Cryolife
14.3.8 Stryker Corporation
14.3.9 Hemostasis
14.3.10 Sanofi
